VolitionRx Limited (VNRX)Healthcare | Medical Devices | Henderson, United States | NYSE American
0.18 USD
+0.00
(1.476%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.17 -0.01 (-0.011%) ⇩ (April 17, 2026, 7:59 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:53 p.m. EDT
VNRX is currently in a highly volatile and uncertain environment, with a recent price decline and no dividend history. While there is some positive news surrounding the company's developments and upcoming earnings, the fundamental metrics such as negative book value, low revenue growth, and poor cash flow suggest a weak financial position. The options market indicates a potential upward bias, but the lack of analyst coverage and the low market cap make it a high-risk investment. Short-term traders might consider buying calls if there is a catalyst, but long-term investors should exercise caution due to the lack of fundamentals and sustainability. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.265833 |
| MSTL | 0.365438 |
| AutoETS | 0.392444 |
| AutoARIMA | 0.402656 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 52% |
| H-stat | 3.34 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.268 |
| Excess Kurtosis | -0.98 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.016 |
| Market Cap | 28,336,448 |
| Forward P/E | 0.75 |
| Beta | 1.33 |
| Website | https://volition.com |
As of April 11, 2026, 2:53 p.m. EDT: The options data shows a strong bias towards calls, with significant open interest and volume on out-of-the-money (OTM) strikes, particularly for the 2026-04-17 expiration. This suggests that speculators are betting on a potential upward move in the stock price, despite the current price being significantly below the strike prices. The high implied volatility (IV) on these calls indicates uncertainty or anticipation of a major price movement. However, the lack of put activity suggests limited bearish sentiment. The overall options activity is mixed, with a focus on long calls, which could indicate a bullish outlook for the short term.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.625 |
| Address1 | 1,489 West Warm Springs Road |
| Address2 | Suite 110 |
| All Time High | 9.28 |
| All Time Low | 0.15 |
| Ask | 0.1596 |
| Ask Size | 100 |
| Average Daily Volume10 Day | 3,404,330 |
| Average Daily Volume3 Month | 11,232,009 |
| Average Volume | 11,232,009 |
| Average Volume10Days | 3,404,330 |
| Beta | 1.327 |
| Bid | 0.175 |
| Bid Size | 1,500 |
| Book Value | -0.272 |
| City | Henderson |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.1788 |
| Current Ratio | 0.169 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.1825 |
| Day Low | 0.1732 |
| Display Name | VolitionRx |
| Earnings Call Timestamp End | 1,775,046,600 |
| Earnings Call Timestamp Start | 1,775,046,600 |
| Earnings Timestamp | 1,774,987,200 |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -20,754,864 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.799 |
| Enterprise To Revenue | 21.615 |
| Enterprise Value | 37,337,732 |
| Eps Current Year | -0.12333 |
| Eps Forward | 0.24 |
| Eps Trailing Twelve Months | -0.22 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.2002 |
| Fifty Day Average Change | -0.021400005 |
| Fifty Day Average Change Percent | -0.10689313 |
| Fifty Two Week Change Percent | -62.5 |
| Fifty Two Week High | 0.94 |
| Fifty Two Week High Change | -0.7612 |
| Fifty Two Week High Change Percent | -0.8097873 |
| Fifty Two Week Low | 0.15 |
| Fifty Two Week Low Change | 0.028799996 |
| Fifty Two Week Low Change Percent | 0.19199996 |
| Fifty Two Week Range | 0.15 - 0.94 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,330,698,600,000 |
| Float Shares | 137,609,263 |
| Forward Eps | 0.24 |
| Forward P E | 0.745 |
| Free Cashflow | -8,515,099 |
| Full Exchange Name | NYSE American |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 1,727,384 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13548 |
| Held Percent Institutions | 0.17086 |
| Implied Shares Outstanding | 158,481,243 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada. |
| Long Name | VolitionRx Limited |
| Market | us_market |
| Market Cap | 28,336,448 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_113678246 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -23,357,028 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 28,336,446 |
| Number Of Analyst Opinions | 5 |
| Open | 0.1792 |
| Operating Cashflow | -19,683,334 |
| Operating Margins | -10.77856 |
| Payout Ratio | 0.0 |
| Phone | 646 650 1351 |
| Post Market Change | -0.011000007 |
| Post Market Change Percent | -6.152129 |
| Post Market Price | 0.1678 |
| Post Market Time | 1,776,470,397 |
| Previous Close | 0.1762 |
| Price Eps Current Year | -1.449769 |
| Price Hint | 4 |
| Price To Book | -0.6573529 |
| Price To Sales Trailing12 Months | 16.404255 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.117 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0026 |
| Regular Market Change Percent | 1.4756 |
| Regular Market Day High | 0.1825 |
| Regular Market Day Low | 0.1732 |
| Regular Market Day Range | 0.1732 - 0.1825 |
| Regular Market Open | 0.1792 |
| Regular Market Previous Close | 0.1762 |
| Regular Market Price | 0.1788 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 3,729,595 |
| Return On Assets | -1.66699 |
| Revenue Growth | 1.332 |
| Revenue Per Share | 0.016 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 135,565,326 |
| Shares Percent Shares Out | 0.0509 |
| Shares Short | 8,074,406 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,421,157 |
| Short Name | VolitionRX Limited |
| Short Percent Of Float | 0.054 |
| Short Ratio | 0.31 |
| Source Interval | 15 |
| State | NV |
| Symbol | VNRX |
| Target High Price | 3.0 |
| Target Low Price | 1.0 |
| Target Mean Price | 1.96 |
| Target Median Price | 1.8 |
| Total Cash | 1,117,028 |
| Total Cash Per Share | 0.007 |
| Total Debt | 11,464,730 |
| Total Revenue | 1,727,384 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.22 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.414 |
| Two Hundred Day Average Change | -0.2352 |
| Two Hundred Day Average Change Percent | -0.56811595 |
| Type Disp | Equity |
| Volume | 3,729,595 |
| Website | https://volition.com |
| Zip | 89,014 |